VC firm
Lilly Asia Ventures (LAV Fund)
Also known as LAV Fund, Lilly Asia Ventures
- Investor type
- VC
- Headquarters
- Grand Cayman, Cayman Islands
- Founded
- 2008
- Assets under management
- $3.9BForm ADV private fund GAV, as of 2026-03-23Source (opens in a new tab)
- Latest fund size
- $547MSEC amount sold, as of 2025-04-10Source (opens in a new tab)
- Funds
- 5
- Legal name
- LAV GLOBAL MANAGEMENT COMPANY LIMITED
Claim, correct or request removal
Record updated 29 September 2026
About
LAV is a leading biomedical venture capital firm, with offices in Hong Kong, Shanghai, and Palo Alto. Our vision is to become the trusted partner for exceptional entrepreneurs seeking smart capital and to build great companies developing breakthrough products that treat diseases and improve human health.
Investment approach
- Thesis
- We are long-term thinkers who bet on people, products and quality science.Source (opens in a new tab)
- Eligibility
- We prefer to receive business plans via e-mail and invite you to submit your non-confidential company information electronically.
- Investing status notes
- Submitting a business plan to Lilly Asia Ventures is an easy process.
Funds
- LAV Fund VII, L.P.
- $547MVintage 2024, Main fund, SEC amount sold
- LAV Fund VI, L.P.
- Main fund
- LAV Fund VI Opportunities, L.P.
- Opportunity
- LAV BIOSCIENCES FUND V, L.P.
- Main fund
- LAV FUND VII, L.P.
- Main fund
SEC registration
- Registered adviser
- LAV GLOBAL MANAGEMENT COMPANY LIMITED
- CRD number
- 300989 (opens in a new tab)
- SEC file number
- 802-115014
- Registration
- Exempt reporting adviser
- Regulatory AUM
- $947Mas of 2026-03-23
- Private funds reported
- 1
- Principal office
- GRAND CAYMAN, Cayman Islands
Locations
- Office
- Shanghai, China
- Office
- Hong Kong, Hong Kong
- Office
- Menlo Park, CA, United States
- Office
- Hong Kong
- Office
- Menlo Park, CA
- Office
- Shanghai
Loading relationship preview